Dual immunomodulator therapy with adalimumab and upadacitinib to treat recalcitrant hidradenitis suppurativa

Zahidul Islam; Solbie Choi; Lucy Wang; Tyler M Andriano; Kristina Campton

doi:10.1016/j.jdcr.2024.12.008

Dual immunomodulator therapy with adalimumab and upadacitinib to treat recalcitrant hidradenitis suppurativa

JAAD Case Rep. 2024 Dec 16:56:74-76. doi: 10.1016/j.jdcr.2024.12.008. eCollection 2025 Feb.

Authors

Zahidul Islam^{1

2}, Solbie Choi¹, Lucy Wang², Tyler M Andriano¹, Kristina Campton¹

Affiliations

¹ Division of Dermatology, Albert Einstein College of Medicine, Bronx, New York.
² School of Medicine, New York Medical College, Valhalla, New York.

No abstract available

Keywords: JAK and anti-TNF therapy; Janus kinase (JAK) inhibitors; TNF- α inhibitor; double-dose adalimumab; dual immunomodulator therapy; hidradenitis suppurativa; refractory; upadacitinib.

Publication types

Case Reports